Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis and uterine fibroids, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. This role leads projects related to early clinical development and implements plans based on the translational strategy for new medicines, supporting development through late phases and registration. Responsibilities include clinical development for study design, development, execution, data readout, and summary of early phase studies in support of late-phase development to NDA/MAA submissions in Neuroscience. The role may lead a multidisciplinary team through complex decisions, integrating input from medical, scientific, regulatory and commercial perspectives with emphasis on clinical trial methodology, management and development of outcome measures. The role may also serve as a resource to program teams for guidance on all matters related to the analysis and communication of clinical data, and may participate in the evaluation of business development, including licensing opportunities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Number of Employees
501-1,000 employees